{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:36:49Z","timestamp":1794332209605,"version":"4.9.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.athoracsur.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:01:12Z","timestamp":1781737272000},"page":"909-920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management Algorithm for Vasoplegic Shock After Cardiac Surgery: An Interdisciplinary Collaboration"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0803-8826","authenticated-orcid":false,"given":"Subhasis","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel","family":"Ortoleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh C.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelci R.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Ivascu","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis J.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando R.","family":"Suero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Wittwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2026.06.013_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ccc.2023.06.002","article-title":"Management of vasoplegic shock in the cardiovascular intensive care unit after cardiac surgery","volume":"40","author":"Suero","year":"2024","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.02.028","article-title":"Vasoplegia syndrome after cardiac surgery: insights into mechanisms and treatment","volume":"13","author":"Castagna","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib3","article-title":"Definitions for vasoplegia associated with on-pump cardiac surgery: a systematic review with meta-analysis","volume":"7","author":"Wieruszewski","year":"2025","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery\u2014review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/j.jvca.2017.10.032","article-title":"Vasoplegia after cardiovascular procedures\u2014pathophysiology and targeted therapy","volume":"32","author":"Shaefi","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.athoracsur.2025.02.022","article-title":"A novel clinical risk score to predict vasoplegia after adult cardiac surgery","volume":"120","author":"Miles","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100916","article-title":"Predictors and impact of prolonged vasoplegia after continuous-flow left ventricular assist device implantation","volume":"3","author":"Lamba","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2024.17123","article-title":"Continuation vs discontinuation of renin-angiotensin system inhibitors before major noncardiac surgery: the Stop-or-Not randomized clinical trial","volume":"332","author":"Legrand","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11748-017-0789-6","article-title":"Risk assessment and outcomes of vasoplegia after cardiac surgery","volume":"65","author":"Tsiouris","year":"2017","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8090-5-17","article-title":"Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-a double-blind randomized study","volume":"5","author":"Papadopoulos","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/j.jvca.2024.02.028","article-title":"Diagnosis and management of vasoplegia in temporary mechanical circulatory support: a narrative review","volume":"38","author":"Ortoleva","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccc.2020.06.004","article-title":"Goal-directed therapy for cardiac surgery","volume":"36","author":"Lobdell","year":"2020","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bja.2025.01.015","article-title":"2024 EACTS\/EACTAIC\/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"134","author":"Wahba","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib16","article-title":"Comparison of central and peripheral arterial blood pressure gradients in critically ill patients: a systematic review and meta-analysis","volume":"6","author":"Hasegawa","year":"2024","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib17","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1711818","article-title":"Restrictive or liberal red-cell transfusion for cardiac surgery","volume":"377","author":"Mazer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.jvca.2018.11.025","article-title":"A systematic approach to the treatment of vasoplegia based on recent advances in pharmacotherapy","volume":"33","author":"Ortoleva","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib20","article-title":"Epidemiology, risk factors and outcomes of norepinephrine use in cardiac surgery with cardiopulmonary bypass: a multicentric prospective study","volume":"42","author":"Guinot","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","article-title":"Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force","volume":"52","author":"Wieruszewski","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13054-025-05505-5","article-title":"Vasopressin use across shock states: international insights from an international ESICM-endorsed survey: the PRESS Survey","volume":"29","author":"Jozwiak","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s13054-024-05212-7","article-title":"Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials","volume":"28","author":"Kotani","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1510\/icvts.2007.159624","article-title":"Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension","volume":"6","author":"Tayama","year":"2007","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/rccm.202005-2050OC","article-title":"Kinetic changes of plasma renin concentrations predict acute kidney injury in cardiac surgery patients","volume":"203","author":"Kullmar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin II and renin kinetics in patients after cardiac surgery","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bja.2023.06.056","article-title":"Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial","volume":"131","author":"Coulson","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: a post-hoc analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) study","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock: a clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.xjon.2025.04.014","article-title":"Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery","volume":"25","author":"Miles","year":"2025","journal-title":"JTCVS Open"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: a multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib36","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1053\/j.jvca.2024.09.148","article-title":"The effects of angiotensin II versus norepinephrine on pulmonary vascular resistance in cardiac surgery: post hoc analysis of a randomized controlled trial","volume":"38","author":"Lim","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/phar.2147","article-title":"Safe use of vasopressin and angiotensin II for patients with circulatory shock","volume":"38","author":"Bauer","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1213\/ANE.0000000000001045","article-title":"Methylene blue: magic bullet for vasoplegia?","volume":"122","author":"Hosseinian","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib39","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib40","article-title":"Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis","volume":"6","author":"Pitre","year":"2024","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib41","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1053\/j.jvca.2024.09.135","article-title":"Hydroxocobalamin versus methylene blue for treatment of vasoplegic shock following cardiopulmonary bypass: a systematic review and meta-analysis","volume":"38","author":"Cadd","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/jcm11041121","article-title":"Early use of methylene blue in vasoplegic syndrome: a 10-year propensity score-matched cohort study","volume":"11","author":"Kofler","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.jvca.2023.09.037","article-title":"Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials","volume":"38","author":"Pruna","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib45","article-title":"Does methylene blue improve outcomes in patients with post-cardiac surgery vasoplegic syndrome?","volume":"40","author":"Zhu","year":"2024","journal-title":"Interdiscip Cardiovasc Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib46","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/j.jvca.2023.12.016","article-title":"Adverse clinical effects associated with non-catecholamine pharmacologic agents for treatment of vasoplegic syndrome in adult cardiac surgery","volume":"38","author":"Hwang","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib48","article-title":"United States Food and Drug Administration package insert","year":"2016","journal-title":"American Regent"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.jvca.2025.02.001","article-title":"Use of hydroxycobolamin in the prevention of vasoplegic syndrome in adult patients undergoing cardiopulmonary bypass: a controlled prospective trial","volume":"39","author":"Salah","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High-dose IV hydroxocobalamin (vitamin B12) in septic shock: a double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (the Intravenous Hydroxocobalamin in Septic Shock Trial)","volume":"163","author":"Patel","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.jvca.2023.03.017","article-title":"Seeing red: hydroxocobalamin and result interference","volume":"37","author":"Ortoleva","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib52","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/jama.2012.14144","article-title":"Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial","volume":"308","author":"Dieleman","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib53","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(15)00273-1","article-title":"Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Whitlock","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/02676591221106324","article-title":"Corticosteroids in patients undergoing cardiac surgery: a meta-analysis of 12,559 patients","volume":"38","author":"Chen","year":"2023","journal-title":"Perfusion"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ejcts\/ezz325","article-title":"The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials","volume":"57","author":"Ng","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib56","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13019-025-03486-8","article-title":"Ascorbic acid and microcirculation in cardiothoracic surgery: a pilot feasibility trial and matched cohort study","volume":"20","author":"Wieruszewski","year":"2025","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib59","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CCM.0000000000001572","article-title":"Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study","volume":"44","author":"Donnino","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.jvca.2019.08.044","article-title":"Sustained high-dose thiamine supplementation in high-risk cardiac patients undergoing cardiopulmonary bypass: a pilot feasibility study (the APPLY trial)","volume":"34","author":"Lomivorotov","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.1996.03530330031025","article-title":"Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled trial","volume":"275","author":"Bennett-Guerrero","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib62","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/shk.0b013e318050c836","article-title":"Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications","volume":"28","author":"Lange","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bjae.2024.10.004","article-title":"Management of vasoplegic shock","volume":"25","author":"Mistry","year":"2025","journal-title":"BJA Educ"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib64","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(20)30531-6","article-title":"Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials","volume":"395","author":"Gaudry","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib65","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MAT.0000000000001933","article-title":"Prognosis of venoarterial extracorporeal membrane oxygenation in mixed, cardiogenic and septic shock","volume":"69","author":"Kim","year":"2023","journal-title":"ASAIO J"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib66","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/CCM.0000000000006003","article-title":"Is it time to reconsider the concept of \"salvage therapy\" in refractory shock?","volume":"51","author":"Wieruszewski","year":"2023","journal-title":"Crit Care Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-019-2420-y","article-title":"Broad spectrum vasopressors: a new approach to the initial management of septic shock?","volume":"23","author":"Chawla","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib68","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.3390\/jcm12237199","article-title":"Adjunctive hemoadsorption therapy with CytoSorb in patients with septic\/vasoplegic shock: a best practice consensus statement","volume":"12","author":"Mitzner","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib69","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.3390\/ijms26094040","article-title":"Glibenclamide serves as a potent vasopressor to treat vasoplegia after cardiopulmonary bypass and reperfusion in a porcine model","volume":"26","author":"Winter","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.athoracsur.2026.06.013_bib70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jtcvs.2025.07.009","article-title":"Tissue perfusion pressure: a novel hemodynamic measure to assess risk of acute kidney injury after cardiac surgery","volume":"171","author":"Miles","year":"2026","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497526005771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497526005771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:03:56Z","timestamp":1794330236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497526005771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0003497526005771"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2026.06.013","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management Algorithm for Vasoplegic Shock After Cardiac Surgery: An Interdisciplinary Collaboration","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of The Society of Thoracic Surgeons.","name":"copyright","label":"Copyright"}]}}